- Home
- STG vs XCUR Comparison
STG vs XCUR Comparison
Compare STG & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STG
- XCUR
- Stock Information
- Founded
- STG 2003
- XCUR 2011
- Country
- STG China
- XCUR United States
- Employees
- STG N/A
- XCUR N/A
- Industry
- STG Other Consumer Services
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- STG Real Estate
- XCUR Health Care
- Exchange
- STG Nasdaq
- XCUR Nasdaq
- Market Cap
- STG 73.4M
- XCUR 59.0M
- IPO Year
- STG 2018
- XCUR N/A
- Fundamental
- Price
- STG $7.35
- XCUR $7.45
- Analyst Decision
- STG
- XCUR
- Analyst Count
- STG 0
- XCUR 0
- Target Price
- STG N/A
- XCUR N/A
- AVG Volume (30 Days)
- STG 8.3K
- XCUR 252.6K
- Earning Date
- STG 08-15-2025
- XCUR 08-12-2025
- Dividend Yield
- STG N/A
- XCUR N/A
- EPS Growth
- STG N/A
- XCUR N/A
- EPS
- STG 3.09
- XCUR N/A
- Revenue
- STG $269,356,990.00
- XCUR N/A
- Revenue This Year
- STG N/A
- XCUR N/A
- Revenue Next Year
- STG N/A
- XCUR N/A
- P/E Ratio
- STG $1.94
- XCUR N/A
- Revenue Growth
- STG N/A
- XCUR N/A
- 52 Week Low
- STG $4.25
- XCUR $1.44
- 52 Week High
- STG $11.06
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- STG 71.07
- XCUR 45.76
- Support Level
- STG $5.51
- XCUR $5.05
- Resistance Level
- STG $5.88
- XCUR $7.36
- Average True Range (ATR)
- STG 0.35
- XCUR 1.04
- MACD
- STG 0.10
- XCUR 0.15
- Stochastic Oscillator
- STG 65.69
- XCUR 65.31
About STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.